- Home
- WHLR vs AIMD Comparison
WHLR vs AIMD Comparison
Compare WHLR & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WHLR | AIMD |
|---|---|---|
| Founded | 2011 | 1984 |
| Country | United States | United States |
| Employees | 49 | 44 |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1M | 9.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | WHLR | AIMD |
|---|---|---|
| Price | $1.34 | $1.49 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 150.5K | 34.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.01 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.65 | $0.44 |
| 52 Week High | $10.05 | $4.50 |
Technical Indicators
Market Signals| Indicator | WHLR | AIMD |
|---|---|---|
| Relative Strength Index (RSI) | 34.14 | 47.21 |
| Support Level | N/A | $1.31 |
| Resistance Level | $2.25 | $1.79 |
| Average True Range (ATR) | 0.15 | 0.11 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 0.55 | 53.12 |
Price Performance
Historical ComparisonAbout WHLR Wheeler Real Estate Investment Trust Inc.
Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Cypress Shopping Center in Boiling Springs, South Carolina, and others.
About AIMD Ainos Inc.
Ainos Inc is a dual-platform AI and biotech company pioneering smelltech and immune therapeutics. Its AI Nose platform and smell language model (SLM) digitize scent into Smell ID, a machine-readable data format, powering intelligent sensing across robotics, smart factories, and healthcare. The company also develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases. It combines AI and Nose, redefining machine perception for the sensory age.